Epsilon M&A Deal Report - Olmix
Transaction Multiples for the Valuation of Private Companies
Private Group led by Motion Equity Partners / Olmix
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Fertilizers & Pesticides > Specialty Chemicals > Chemicals > Fertilizers & Pesticides - Manufacturers
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ns | ns | ns | |||||
Current |
Multiple available | |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Fertilizers & Pesticides - Manufacturers » = 38
Date | Acquirer | Target | Country | Multiples | See details |
04/04/2018 | Funding round led by LFPI, Idia Capital Invest and Unigrains | Bioline Group (Invivo Agrosciences) | Paris | * | 103213 |
06/07/2018 | Olmix | Amendis | Côtes-D'Armor | * | 103170 |
Source: Epsilon Research / EMAT